SlideShare a Scribd company logo
MEASUREMENT OF
GLOMERULAR FILTRATION
RATE
BY
PAVITHRA .V
V PHARM-D
It is the volume of
fluid filtered from
the renal
Glomerular
capillaries into
the Bowman's
capsule per unit
time.
It is calculated by
measuring any chemical
that has a steady level in
the blood, and is freely
filtered but neither
reabsorbed nor secreted
by the kidneys
GFR is typically recorded
in units of volume per time.
In day to day clinical practice an estimation
of glomerular filtration rate (GFR) is required
for various reasons viz,
a) assessment of renal function.
b) severity of renal disease
c) calculation of proper drug dosage and
d) appraisal of renal involvement in systemic
diseases.
IMPORTANCE OF GFR MEASUREMENT
I. CLEARENCE METHODS:
-EXOGENOUS SUBSTANCE
-ENDOGENOUS SUBSTANCE
II. FROM PLASMA CREATININE
III. BY NEW ENDOGENOUS MARKERS
METHODS USED FOR
MEASURING GFR
A) Exogenous Substances
i) Inulin:- (MW 5200 dalton), a polymer of fructose is considered the
gold standard for the estimation of GFR. It is freely filtered by
glomerulus, and is neither reabsorbed nor secreted by the renal tubules.
It is metabolically inert and cleared only by the kidney. It requires
constant IV infusion to maintain plasma level and once steady state has
been achieved, plasma and timed urine specimen levels are measured.
However, analysis of inulin is technically demanding, time consuming,
labour intensive, costly and unsuitable for out patient use. The reference
ranges for the GFR in normal individuals given by Smith are 88 to
174 ml/min/1.73m2 for males and 87 to 147ml.min/1.73m2 for females .
ii)Non-radiolabelled contrast media:- In addition to inulin, non-
radiolabelled contrast media infusion (iothalamate / iohexol) have
been used to measure GFR. One advantage is that urography and an
estimation of GFR can be done at a single examination (3).
Cumbersome measurement makes it unsuitable for day to day
clinical practice.
iii)Radiolabelled compounds:- A number of radiolabelled
chelates have been used to assess the GFR in man, as very small
non-toxic amounts of the compound can be given and can be
measured even at very low concentrations using conventional
counters. Amongst these are [51Cr] EDTA, [125I] iothalamate,
[99Tcm] DTPA, [131I] Hippuran to mention a few . Disadvantages
are that some radiation is administered, radiopharmaceuticals
are more expensive, Gamma camera and skilled personnel are
needed. Hence these chelates cannot be used routinely to assess
GFR.
• B) Endogenous Substances
i) Urea (MW 60 dalton) was one of the first
markers for assessing GFR (6) but at present is
not used in clinical practice due to several
reasons. Urea production is variable and varies
with protein intake. It is readily reabsorbed by
tubules and again amount of reabsorption is
variable. Hydration status of the individual also
affects urea clearance markedly, increased
plasma levels accompany decreased urine flow
in patients with depleted intravascular volume.
In addition many substances may interfere with
its estimation.
One method of determining GFR from creatinine is
to collect urine (usually for 24-hours) to determine
the amount of creatinine that was removed from
the blood over a given time interval.
Creatinine clearance (CCr) is calculated from the
creatinine concentration in the collected urine
sample (UCr), urine flow rate (V), and the plasma
concentration (PCr).
ii.)creatinine clearance
PRACTICE PROBLEM 1:
A person has a plasmacreatinine concentration
of 0.01 mg/ml and in 1 hour produces 60ml of
urine with a creatinine concentration of 1.25
mg/mL.
ANSWER:
II. PLASMA CREATININE
•Approximation of GFR from plasma creatinine may give unreliable
results because plasma creatinine is not only dependent on GFR but
also on muscle mass which varies with age, weight and gender.
• In cirrhosis and diseases with reduced muscle mass, plasma
Creatinine is low, conversely a high protein intake can lead to 10%
increase in plasma creatinine . Further more a marked reduction in
GFR can be present before it is reflected in plasma creatinine
concentration above the upper limit of normal range
•. To improve the estimation of GFR from plasma creatinine
concentration, formulas which incorporate variables like age,
weight, height and gender can be used. Some commonly used
formulas are shown in Table . The most widely employed and best
validated for use in adults is that of Cockroft and Gault (15).
PRACTISE PROBLEM 2 :
III: GFR estimation by new endogenous
markers:-
• a) ß2-Microglobulin (M.W 11815 dalton) is filtered at
glomerulus like water. Subsequently >99.9% is reabsorbed and
degraded in renal tubule. Because it is filtered so readily, its
plasma concentration in health is low(average 1.5mg/ L). The
plasma concentration increases as the glomerular filteration rate
declines reaching about 40mg/l in terminal uremia. The
logarithm of the plasma concentration is linearly related to the
logarithm of glomerular filtration rate throughout the whole
range so that it provides an excellent marker for renal
dysfunction. The plasma concentration of ß2-microglobular is
not affected by muscle mass nor by sex of individual. As its
estimation involves expensive radioimmunoassay it has not yet
become more useful in clinical practice. Also in patients with
some tumors and inflammatory diseases there may be increase
in plasma concentration due to increased production rather
than reduced clearance (19).
• b) Cystatin C is a 13-KD protease inhibitor
which is produced by all nucleated cells and is
independent of muscle mass and sex. Its
production, unlike ß2-microglobulin is not
affected by inflammatory states or
malignancies. Cystatin C is eliminated by
glomerular filtration and metabolized by
proximal tubular cells. Its measurement has
been proposed as an alternative and more
sensitive marker of GFR than creatinine
particularly in patients with slight to
moderately decreased GFR .
Creatinine clearance remains the most widely
used test for estimating GFR in clinical practice
despite its many disadvantages and problems.
Appreciating the limitations, GFR can be
estimated with reasonable accuracy and
precision from serum creatinine alone with Clcr
prediction formulas, Cystatin C could well enter
the clinical field as a routine method for
estimating GFR in the near future
http://www.nlm.nih.gov/medline
plus/ency/article/00 7305.htm
THANK U!

More Related Content

What's hot

Drug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide shareDrug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide share
javvadhasan
 
Dose adjustment in renal disorder
Dose adjustment in renal disorderDose adjustment in renal disorder
Dose adjustment in renal disorder
Dr. Ankit Gaur
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
pavithra vinayak
 
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Abel C. Mathew
 
Individualization of drug dosage regimen
Individualization of drug dosage regimenIndividualization of drug dosage regimen
Individualization of drug dosage regimen
Dr. Ramesh Bhandari
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Kevin John
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
Saleem Cology
 
Extracorporeal removal of drugs
Extracorporeal removal of drugsExtracorporeal removal of drugs
Extracorporeal removal of drugs
Dr. Ramesh Bhandari
 
Nomograms
NomogramsNomograms
Nomograms
Dr. Ankit Gaur
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
PARUL UNIVERSITY
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
pavithra vinayak
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
Dr. Ashish singh parihar
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
Soujanya Pharm.D
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrens
Dr. Ramesh Bhandari
 
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
pavithra vinayak
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
pavithra vinayak
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
M.Arumuga Vignesh
 
Designing of dosage regimen
Designing of dosage regimenDesigning of dosage regimen
Designing of dosage regimen
Dr. Ramesh Bhandari
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmDDr.Sohel Memon
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
pavithra vinayak
 

What's hot (20)

Drug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide shareDrug dosing in elderly, infant and obese patient slide share
Drug dosing in elderly, infant and obese patient slide share
 
Dose adjustment in renal disorder
Dose adjustment in renal disorderDose adjustment in renal disorder
Dose adjustment in renal disorder
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
 
Individualization of drug dosage regimen
Individualization of drug dosage regimenIndividualization of drug dosage regimen
Individualization of drug dosage regimen
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 
Extracorporeal removal of drugs
Extracorporeal removal of drugsExtracorporeal removal of drugs
Extracorporeal removal of drugs
 
Nomograms
NomogramsNomograms
Nomograms
 
Individualization of dosage regimen
Individualization of dosage regimenIndividualization of dosage regimen
Individualization of dosage regimen
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Dosing in childrens
Dosing in childrensDosing in childrens
Dosing in childrens
 
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Genetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolismGenetic polymorphism in drug metabolism
Genetic polymorphism in drug metabolism
 
Designing of dosage regimen
Designing of dosage regimenDesigning of dosage regimen
Designing of dosage regimen
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
 

Similar to Mesurement of GFR and creatinine clearence

Pitfalls in estimating renal failure in the elderly by eGFR
Pitfalls in estimating renal failure in the elderly by eGFRPitfalls in estimating renal failure in the elderly by eGFR
Pitfalls in estimating renal failure in the elderly by eGFR
Ranjit Singh
 
Renal function test
Renal function test   Renal function test
Renal function test docmveg
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
Dr. Prem Mohan Jha
 
Cystatin-C-as-a-Marker-of-Renal-Function.pptx
Cystatin-C-as-a-Marker-of-Renal-Function.pptxCystatin-C-as-a-Marker-of-Renal-Function.pptx
Cystatin-C-as-a-Marker-of-Renal-Function.pptx
DrRhutaShah1
 
RFT.pptx
RFT.pptxRFT.pptx
RFT.pptx
kedirnigussie
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
Pallavi Kurra
 
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
ijtsrd
 
limitation and scope.pptx
limitation and scope.pptxlimitation and scope.pptx
limitation and scope.pptx
roshanchanchlani
 
Kidney function test
Kidney function testKidney function test
Kidney function test
beedkar
 
Determinant of Glomerular Filtration
Determinant of Glomerular FiltrationDeterminant of Glomerular Filtration
Determinant of Glomerular Filtration
GovtRoyapettahHospit
 
Approach to Chronic Kidney Diseases
Approach to Chronic Kidney DiseasesApproach to Chronic Kidney Diseases
Approach to Chronic Kidney Diseases
Beka Aberra
 
End stage renal disease
End stage renal diseaseEnd stage renal disease
End stage renal disease
Prasenjit Gogoi
 
Cystatin C - Early Risk Assessment of Renal Impairment MAY18
Cystatin C - Early Risk Assessment of Renal Impairment MAY18Cystatin C - Early Risk Assessment of Renal Impairment MAY18
Cystatin C - Early Risk Assessment of Renal Impairment MAY18
Randox Reagents
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
Malini Garg
 
Modeling Algorithm of Estimation Of Renal Function by the Cockcroft and M...
Modeling  Algorithm  of Estimation Of Renal Function  by the Cockcroft  and M...Modeling  Algorithm  of Estimation Of Renal Function  by the Cockcroft  and M...
Modeling Algorithm of Estimation Of Renal Function by the Cockcroft and M...
hiij
 
Kidney function test
Kidney function testKidney function test
Kidney function test
Venkata Karthik
 
Plasma exchange
Plasma exchangePlasma exchange
Plasma exchange
Dr. Prem Mohan Jha
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
dr_ekbalabohashem
 
Creatinine and Creatinine Clearance
Creatinine and Creatinine ClearanceCreatinine and Creatinine Clearance
Creatinine and Creatinine Clearance
Mostafa Sabry
 
Antibiotic Dosing During Renal Failure
Antibiotic Dosing During Renal FailureAntibiotic Dosing During Renal Failure
Antibiotic Dosing During Renal Failure
nels1937
 

Similar to Mesurement of GFR and creatinine clearence (20)

Pitfalls in estimating renal failure in the elderly by eGFR
Pitfalls in estimating renal failure in the elderly by eGFRPitfalls in estimating renal failure in the elderly by eGFR
Pitfalls in estimating renal failure in the elderly by eGFR
 
Renal function test
Renal function test   Renal function test
Renal function test
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
 
Cystatin-C-as-a-Marker-of-Renal-Function.pptx
Cystatin-C-as-a-Marker-of-Renal-Function.pptxCystatin-C-as-a-Marker-of-Renal-Function.pptx
Cystatin-C-as-a-Marker-of-Renal-Function.pptx
 
RFT.pptx
RFT.pptxRFT.pptx
RFT.pptx
 
Dose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failureDose Adjustment in renal and hepatic failure
Dose Adjustment in renal and hepatic failure
 
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
Correlation of Serum Creatinine Based Calculation of Glomerular Filtration Ra...
 
limitation and scope.pptx
limitation and scope.pptxlimitation and scope.pptx
limitation and scope.pptx
 
Kidney function test
Kidney function testKidney function test
Kidney function test
 
Determinant of Glomerular Filtration
Determinant of Glomerular FiltrationDeterminant of Glomerular Filtration
Determinant of Glomerular Filtration
 
Approach to Chronic Kidney Diseases
Approach to Chronic Kidney DiseasesApproach to Chronic Kidney Diseases
Approach to Chronic Kidney Diseases
 
End stage renal disease
End stage renal diseaseEnd stage renal disease
End stage renal disease
 
Cystatin C - Early Risk Assessment of Renal Impairment MAY18
Cystatin C - Early Risk Assessment of Renal Impairment MAY18Cystatin C - Early Risk Assessment of Renal Impairment MAY18
Cystatin C - Early Risk Assessment of Renal Impairment MAY18
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Modeling Algorithm of Estimation Of Renal Function by the Cockcroft and M...
Modeling  Algorithm  of Estimation Of Renal Function  by the Cockcroft  and M...Modeling  Algorithm  of Estimation Of Renal Function  by the Cockcroft  and M...
Modeling Algorithm of Estimation Of Renal Function by the Cockcroft and M...
 
Kidney function test
Kidney function testKidney function test
Kidney function test
 
Plasma exchange
Plasma exchangePlasma exchange
Plasma exchange
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
 
Creatinine and Creatinine Clearance
Creatinine and Creatinine ClearanceCreatinine and Creatinine Clearance
Creatinine and Creatinine Clearance
 
Antibiotic Dosing During Renal Failure
Antibiotic Dosing During Renal FailureAntibiotic Dosing During Renal Failure
Antibiotic Dosing During Renal Failure
 

More from pavithra vinayak

Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.
pavithra vinayak
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
pavithra vinayak
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
pavithra vinayak
 
protocol writing in clinical research
protocol writing in clinical research protocol writing in clinical research
protocol writing in clinical research
pavithra vinayak
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
pavithra vinayak
 
Anticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacologyAnticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacology
pavithra vinayak
 
Antianginals - pharmacology
Antianginals - pharmacologyAntianginals - pharmacology
Antianginals - pharmacology
pavithra vinayak
 
Alpha blockers class
Alpha blockers   classAlpha blockers   class
Alpha blockers class
pavithra vinayak
 
03. adrenergic drugs
03. adrenergic drugs 03. adrenergic drugs
03. adrenergic drugs
pavithra vinayak
 
Vasomotor reversal of dale
Vasomotor reversal of daleVasomotor reversal of dale
Vasomotor reversal of dale
pavithra vinayak
 
Alcohol class
Alcohol classAlcohol class
Alcohol class
pavithra vinayak
 
Gene expression
Gene expressionGene expression
Gene expression
pavithra vinayak
 
Glaucoma
GlaucomaGlaucoma
Congestive heartfailure
Congestive heartfailureCongestive heartfailure
Congestive heartfailure
pavithra vinayak
 
Paediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with linksPaediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with links
pavithra vinayak
 
2. antiarrhythmic drugs_
2. antiarrhythmic drugs_2. antiarrhythmic drugs_
2. antiarrhythmic drugs_
pavithra vinayak
 
Leprosy
LeprosyLeprosy
allergies due to food
allergies due to foodallergies due to food
allergies due to food
pavithra vinayak
 
Complications of diabetes mellitus
Complications of diabetes mellitusComplications of diabetes mellitus
Complications of diabetes mellitus
pavithra vinayak
 
Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiation
pavithra vinayak
 

More from pavithra vinayak (20)

Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
 
protocol writing in clinical research
protocol writing in clinical research protocol writing in clinical research
protocol writing in clinical research
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Anticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacologyAnticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacology
 
Antianginals - pharmacology
Antianginals - pharmacologyAntianginals - pharmacology
Antianginals - pharmacology
 
Alpha blockers class
Alpha blockers   classAlpha blockers   class
Alpha blockers class
 
03. adrenergic drugs
03. adrenergic drugs 03. adrenergic drugs
03. adrenergic drugs
 
Vasomotor reversal of dale
Vasomotor reversal of daleVasomotor reversal of dale
Vasomotor reversal of dale
 
Alcohol class
Alcohol classAlcohol class
Alcohol class
 
Gene expression
Gene expressionGene expression
Gene expression
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Congestive heartfailure
Congestive heartfailureCongestive heartfailure
Congestive heartfailure
 
Paediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with linksPaediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with links
 
2. antiarrhythmic drugs_
2. antiarrhythmic drugs_2. antiarrhythmic drugs_
2. antiarrhythmic drugs_
 
Leprosy
LeprosyLeprosy
Leprosy
 
allergies due to food
allergies due to foodallergies due to food
allergies due to food
 
Complications of diabetes mellitus
Complications of diabetes mellitusComplications of diabetes mellitus
Complications of diabetes mellitus
 
Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiation
 

Recently uploaded

The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 

Recently uploaded (20)

The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 

Mesurement of GFR and creatinine clearence

  • 2. It is the volume of fluid filtered from the renal Glomerular capillaries into the Bowman's capsule per unit time.
  • 3. It is calculated by measuring any chemical that has a steady level in the blood, and is freely filtered but neither reabsorbed nor secreted by the kidneys GFR is typically recorded in units of volume per time.
  • 4.
  • 5. In day to day clinical practice an estimation of glomerular filtration rate (GFR) is required for various reasons viz, a) assessment of renal function. b) severity of renal disease c) calculation of proper drug dosage and d) appraisal of renal involvement in systemic diseases. IMPORTANCE OF GFR MEASUREMENT
  • 6. I. CLEARENCE METHODS: -EXOGENOUS SUBSTANCE -ENDOGENOUS SUBSTANCE II. FROM PLASMA CREATININE III. BY NEW ENDOGENOUS MARKERS METHODS USED FOR MEASURING GFR
  • 7. A) Exogenous Substances i) Inulin:- (MW 5200 dalton), a polymer of fructose is considered the gold standard for the estimation of GFR. It is freely filtered by glomerulus, and is neither reabsorbed nor secreted by the renal tubules. It is metabolically inert and cleared only by the kidney. It requires constant IV infusion to maintain plasma level and once steady state has been achieved, plasma and timed urine specimen levels are measured. However, analysis of inulin is technically demanding, time consuming, labour intensive, costly and unsuitable for out patient use. The reference ranges for the GFR in normal individuals given by Smith are 88 to 174 ml/min/1.73m2 for males and 87 to 147ml.min/1.73m2 for females .
  • 8. ii)Non-radiolabelled contrast media:- In addition to inulin, non- radiolabelled contrast media infusion (iothalamate / iohexol) have been used to measure GFR. One advantage is that urography and an estimation of GFR can be done at a single examination (3). Cumbersome measurement makes it unsuitable for day to day clinical practice. iii)Radiolabelled compounds:- A number of radiolabelled chelates have been used to assess the GFR in man, as very small non-toxic amounts of the compound can be given and can be measured even at very low concentrations using conventional counters. Amongst these are [51Cr] EDTA, [125I] iothalamate, [99Tcm] DTPA, [131I] Hippuran to mention a few . Disadvantages are that some radiation is administered, radiopharmaceuticals are more expensive, Gamma camera and skilled personnel are needed. Hence these chelates cannot be used routinely to assess GFR.
  • 9. • B) Endogenous Substances i) Urea (MW 60 dalton) was one of the first markers for assessing GFR (6) but at present is not used in clinical practice due to several reasons. Urea production is variable and varies with protein intake. It is readily reabsorbed by tubules and again amount of reabsorption is variable. Hydration status of the individual also affects urea clearance markedly, increased plasma levels accompany decreased urine flow in patients with depleted intravascular volume. In addition many substances may interfere with its estimation.
  • 10. One method of determining GFR from creatinine is to collect urine (usually for 24-hours) to determine the amount of creatinine that was removed from the blood over a given time interval. Creatinine clearance (CCr) is calculated from the creatinine concentration in the collected urine sample (UCr), urine flow rate (V), and the plasma concentration (PCr). ii.)creatinine clearance
  • 11. PRACTICE PROBLEM 1: A person has a plasmacreatinine concentration of 0.01 mg/ml and in 1 hour produces 60ml of urine with a creatinine concentration of 1.25 mg/mL.
  • 13. II. PLASMA CREATININE •Approximation of GFR from plasma creatinine may give unreliable results because plasma creatinine is not only dependent on GFR but also on muscle mass which varies with age, weight and gender. • In cirrhosis and diseases with reduced muscle mass, plasma Creatinine is low, conversely a high protein intake can lead to 10% increase in plasma creatinine . Further more a marked reduction in GFR can be present before it is reflected in plasma creatinine concentration above the upper limit of normal range •. To improve the estimation of GFR from plasma creatinine concentration, formulas which incorporate variables like age, weight, height and gender can be used. Some commonly used formulas are shown in Table . The most widely employed and best validated for use in adults is that of Cockroft and Gault (15).
  • 14.
  • 15.
  • 16.
  • 18. III: GFR estimation by new endogenous markers:- • a) ß2-Microglobulin (M.W 11815 dalton) is filtered at glomerulus like water. Subsequently >99.9% is reabsorbed and degraded in renal tubule. Because it is filtered so readily, its plasma concentration in health is low(average 1.5mg/ L). The plasma concentration increases as the glomerular filteration rate declines reaching about 40mg/l in terminal uremia. The logarithm of the plasma concentration is linearly related to the logarithm of glomerular filtration rate throughout the whole range so that it provides an excellent marker for renal dysfunction. The plasma concentration of ß2-microglobular is not affected by muscle mass nor by sex of individual. As its estimation involves expensive radioimmunoassay it has not yet become more useful in clinical practice. Also in patients with some tumors and inflammatory diseases there may be increase in plasma concentration due to increased production rather than reduced clearance (19).
  • 19. • b) Cystatin C is a 13-KD protease inhibitor which is produced by all nucleated cells and is independent of muscle mass and sex. Its production, unlike ß2-microglobulin is not affected by inflammatory states or malignancies. Cystatin C is eliminated by glomerular filtration and metabolized by proximal tubular cells. Its measurement has been proposed as an alternative and more sensitive marker of GFR than creatinine particularly in patients with slight to moderately decreased GFR .
  • 20.
  • 21. Creatinine clearance remains the most widely used test for estimating GFR in clinical practice despite its many disadvantages and problems. Appreciating the limitations, GFR can be estimated with reasonable accuracy and precision from serum creatinine alone with Clcr prediction formulas, Cystatin C could well enter the clinical field as a routine method for estimating GFR in the near future
  • 22.